AMY KEEFE: Open Payments
NPI 1508890096 · GREENSBURG, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$260 in 12 payments from 11 companies in 2025. Trend: 2023 $1,405 · 2024 $898 · 2025 $260
Food & beverage: $260
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $50 |
| Aurinia Pharma U.S., Inc. | 1 | $27 |
| Janssen Biotech, Inc. | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $24 |
| Actelion Pharmaceuticals US, Inc. | 1 | $24 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| ABBVIE INC. | 1 | $19 |
| Lilly USA, LLC | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Alexion Pharmaceuticals, Inc. | 1 | $17 |
Products named: ENBREL, LUPKYNIS, TREMFYA, COSENTYX, UPTRAVI, BENLYSTA, UPLIZNA, RINVOQ.
Industry payments across PA — which companies pay providers there.
